Iovance Biotherapeutics Inc (IOVA) Stock Price, Quote & News

Company Profile

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic melanom...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 260 7120

Website: www.iovance.com

Address:

825 Industrial Road, Suite 100, San Carlos, United States

Gius_me Oct. 7 at 6:37 AM

$IOVA why complaining iovamily? Lung, endo, 4001, earning and maybe an update on 301…nothing changed from yesterday. They can start dropping readout and new data any day…just wait and see, less than 3 months till the end of the year

0 · Reply

Quadman5 Oct. 7 at 5:48 AM

$IOVA Interesting article on voucher program. https://www.brookings.edu/articles/fdas-new-commissioners-national-priority-voucher-has-lofty-goals-can-it-deliver/

0 · Reply

Strategy2019 Oct. 7 at 5:15 AM

$IOVA Yesterday I sold one share. Today I buy one share back. My profit will be $ 0.0000456788. The other 500,000 share I will hold for making big big money on 7th of November 2025

0 · Reply

Strategy2019 Oct. 7 at 5:09 AM

$IOVA Do not care about short selling Next financial in one month. Few days only. 23 trading days for Shorts to cover..... Squeeeeeeeze very soon I like it

0 · Reply

richhox Oct. 7 at 3:51 AM

$IOVA So nothing came out of MESA? Has Iovance had a presentation? ANYTHING??

1 · Reply

Lilwopjob Oct. 7 at 3:24 AM

$IOVA hey guys wanna cry? Check out sprb today

0 · Reply

KangaroooJack Oct. 7 at 3:22 AM

$IOVA HAHAH UNBELIEVABLE! I found Smallwood management. Lead analyst 88 yr old Chester, placed the 9 shares order from this office house. He was looking to diversify Smallwood’s 96% bond port. Just keep it gramps! you’ll need it when they pull Medicare

0 · Reply

strategicmind Oct. 7 at 3:05 AM

$IOVA this board is hilarious. Probably the best on ST!! Hahah. I can feel the frustration. Lot of smart people here. Let’s hope things can get turned around. Perhaps better earnings? Lung data?

0 · Reply

KangaroooJack Oct. 7 at 2:54 AM

$IOVA 9 shares today from Smallwood wealth management. Must be a mom and pop operation. Way to dig deep cucks!

3 · Reply

Skipper6 Oct. 7 at 2:26 AM

$IOVA ...get rid of Fred, please!!! He's a nothing and getting paid almost $ 5M/yr.... Wayne??? Not so sure???

1 · Reply

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Aug 29, 2025, 8:30 AM EDT - 5 weeks ago

Iovance Biotherapeutics to Present at Upcoming Conferences

Aug 21, 2025, 4:56 PM EDT - 6 weeks ago

Iovance Biotherapeutics: Tough Decisions Being Made But Catalysts In H2'25

Aug 18, 2025, 4:15 PM EDT - 7 weeks ago

Iovance's Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma

Aug 8, 2025, 3:15 AM EDT - 2 months ago

Iovance Biotherapeutics, Inc. (IOVA) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:01 PM EDT - 2 months ago

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025

Jul 23, 2025, 12:08 PM EDT - 2 months ago

Here's why Iova stock surged 32% today and why the rally might not be over

Jul 18, 2025, 12:02 PM EDT - 2 months ago

Iovance: I'm Switching From Sell To Buy Despite Likely Approval For Rival Drug

Jul 15, 2025, 7:30 AM EDT - 2 months ago

Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer

Jul 14, 2025, 9:04 AM EDT - 3 months ago

IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV

Jul 14, 2025, 7:30 AM EDT - 3 months ago

Real-World Data Demonstrate a 49% Response Rate for Commercial Amtagvi® in Patients with Advanced Melanoma

Jul 11, 2025, 10:32 AM EDT - 3 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jul 10, 2025, 4:01 PM EDT - 3 months ago

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D.

Jul 10, 2025, 8:18 AM EDT - 3 months ago

IOVA COURT NOTICE: Iovance Biotherapeutics Investors may have been Affected by Fraud – Contact BFA Law by the July 14 Legal Deadline (NASDAQ:IOVA)

Jul 3, 2025, 7:35 AM EDT - 3 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jul 2, 2025, 5:46 PM EDT - 3 months ago

Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure– Hagens Berman

Jun 28, 2025, 7:46 AM EDT - 3 months ago

IOVA INVESTOR DEADLINE: Iovance Biotherapeutics Investors with Losses may have been Affected by Fraud – Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Jun 26, 2025, 4:45 PM EDT - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit – IOVA

Jun 26, 2025, 9:00 AM EDT - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit - IOVA

Jun 24, 2025, 12:03 PM EDT - 3 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jun 20, 2025, 9:07 AM EDT - 3 months ago

IOVA COURT REMINDER: Iovance Biotherapeutics, Inc. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Jun 18, 2025, 2:34 PM EDT - 3 months ago

Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure – Hagens Berman

Jun 18, 2025, 8:38 AM EDT - 3 months ago

IOVA NOTICE: Did Iovance Biotherapeutics, Inc. Mislead Investors? Contact BFA Law by July 14 Court Deadline if You Suffered Losses (NASDAQ:IOVA)

Jun 16, 2025, 8:17 AM EDT - 4 months ago

IOVA SHAREHOLDER REPORT: Iovance Biotherapeutics, Inc. was Sued for Fraud – Investors with Losses are Notified to Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Jun 10, 2025, 8:47 AM EDT - 4 months ago

IOVA LEGAL NOTICE: Lose Money when Iovance Biotherapeutics, Inc. Stock Plummeted 44%? Contact BFA Law by the July 14 Court Deadline (NASDAQ:IOVA)

Jun 10, 2025, 8:45 AM EDT - 4 months ago

Iovance Biotherapeutics to Present at Upcoming Conference

Jun 8, 2025, 8:18 AM EDT - 4 months ago

IOVA INVESTOR NEWS: Iovance Biotherapeutics, Inc. has been Sued for Securities Fraud – Contact BFA Law before July 14 Deadline (NASDAQ:IOVA)

Gius_me Oct. 7 at 6:37 AM

0 · Reply

Quadman5 Oct. 7 at 5:48 AM

$IOVA Interesting article on voucher program. https://www.brookings.edu/articles/fdas-new-commissioners-national-priority-voucher-has-lofty-goals-can-it-deliver/

0 · Reply

Strategy2019 Oct. 7 at 5:15 AM

$IOVA Yesterday I sold one share. Today I buy one share back. My profit will be $ 0.0000456788. The other 500,000 share I will hold for making big big money on 7th of November 2025

0 · Reply

Strategy2019 Oct. 7 at 5:09 AM

$IOVA Do not care about short selling Next financial in one month. Few days only. 23 trading days for Shorts to cover..... Squeeeeeeeze very soon I like it

0 · Reply

richhox Oct. 7 at 3:51 AM

$IOVA So nothing came out of MESA? Has Iovance had a presentation? ANYTHING??

1 · Reply

Lilwopjob Oct. 7 at 3:24 AM

$IOVA hey guys wanna cry? Check out sprb today

0 · Reply

KangaroooJack Oct. 7 at 3:22 AM

0 · Reply

strategicmind Oct. 7 at 3:05 AM

$IOVA this board is hilarious. Probably the best on ST!! Hahah. I can feel the frustration. Lot of smart people here. Let’s hope things can get turned around. Perhaps better earnings? Lung data?

0 · Reply

KangaroooJack Oct. 7 at 2:54 AM

$IOVA 9 shares today from Smallwood wealth management. Must be a mom and pop operation. Way to dig deep cucks!

3 · Reply

Skipper6 Oct. 7 at 2:26 AM

$IOVA ...get rid of Fred, please!!! He's a nothing and getting paid almost $ 5M/yr.... Wayne??? Not so sure???

1 · Reply

ducruacuteo11 Oct. 7 at 1:17 AM

$IOVA this stock is psycho. It goes up and down daily 5% for no reasons. Lol.

1 · Reply

Stockrichz Oct. 7 at 1:09 AM

$IOVA Amtagvi works But there's not a good chance that it's going to be a good product Like casino.. can you believe this? So it’s very expensive and no profit this company lack the ability to improve this.

1 · Reply

Stockrichz Oct. 7 at 1:02 AM

$IOVA So what happen to 2H?? Nothing happens this year This is garbage

0 · Reply

DanSfera Oct. 7 at 12:56 AM

$IOVA more than a chart 📈

1 · Reply

Xanderzzzzzzz Oct. 7 at 12:24 AM

$IOVA

0 · Reply

KangaroooJack Oct. 7 at 12:13 AM

$IOVA do another one convict

0 · Reply

Quadman5 Oct. 6 at 11:58 PM

$IOVA "Back onto combo(ipi/nivo) treatment, hoping for positive results with minimal side effects. The previous times this treatment destroyed her adrenal gland as well as her thyroid gland, hopefully the 3rd times the charm. " Quote from stage 4 mm patient. Treatments make little sense to me. I've seen multiple comments from individuals with destroyed thyroid and adrenal .

2 · Reply

lovemeLUNGtime Oct. 6 at 11:13 PM

$IOVA

0 · Reply

MS1974 Oct. 6 at 11:09 PM

$IOVA Putin and Xi Jinping talked about immortality, we need to take a step forward here☝️

0 · Reply

ECHorizon Oct. 6 at 10:49 PM

$IOVA for what’s its worth, today’s short volume was 56.6%. The fuckery continues. Let’s hope we get a strong bounce from $2.10 to $2.15 range and close the week strong.

0 · Reply

dogbone98 Oct. 6 at 10:46 PM

$IOVA Just one note about the CNPV (FDA voucher) awards Birdsnpars mentioned below. If IOVA is indeed being considered for a CNPV award, then that would put any potential bo on hold, because the awards can't go to a company owned by a BP. However, once the voucher is awarded, the receiving company can be bought-out and the award transfers, according to the rules on the FDA website.

4 · Reply

JohnEss Oct. 6 at 10:32 PM

$IOVA https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-iova/iovance-biotherapeutics/news/iovance-biotherapeutics-iova-valuation-in-focus-after-recent

0 · Reply

Market Cap	846.74M
Revenue (ttm)	164.07M
Net Income (ttm)	-372.18M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-226.84%
Debt to Equity Ratio	0.00

Volume	15,693,700
Avg Vol	12,628,062
Day's Range	N/A - N/A
Shares Out	361.85M
Stochastic %K	59%
Beta	0.83
Analysts	Sell
Price Target	$9.10